Carvana (NYSE: CVNA) insider plans 1,527-share sale and details 10b5-1 trades

Rhea-AI Filing Summary

An insider of CVNA filed a Form 144 notice to potentially sell 1,527 shares of common stock through Morgan Stanley Smith Barney on the NYSE. The filing lists an aggregate market value of $721,858.71 for these shares and notes that 141,423,193 shares of the same class were outstanding at the time. The shares to be sold were acquired on 12/12/2025 by exercising stock options for cash on that same date.

The notice also details prior sales under a Rule 10b5-1 trading plan for Paul Breaux over the past three months. These include 8,473 shares sold on 12/11/2025 for $4,024,675.00, 20,000 shares sold on 12/08/2025 for $8,770,000.00, and 15,000 shares sold on 10/01/2025 for $5,970,000.00. By signing, the seller represents that they do not know of any undisclosed material adverse information about the issuer.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	1527	721858.71	141423193	12/12/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/12/2025	Exercise of Stock Options	Issuer			1527	12/12/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for PAUL BREAUX 300 E. Rio Salado Parkway Tempe AZ 85281	Common	12/11/2025	8473	4024675.00
10b5-1 Sales for PAUL BREAUX 300 E. Rio Salado Parkway Tempe AZ 85281	Common	12/08/2025	20000	8770000.00
10b5-1 Sales for PAUL BREAUX 300 E. Rio Salado Parkway Tempe AZ 85281	Common	10/01/2025	15000	5970000.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does CVNA's Form 144 filing disclose about insider share sales?

The Form 144 discloses that an insider of CVNA may sell 1,527 shares of common stock on the NYSE, with an aggregate market value of $721,858.71, through Morgan Stanley Smith Barney.

How many CVNA shares are planned to be sold under this Form 144?

The notice covers a potential sale of 1,527 shares of CVNA common stock, as listed in the section describing the securities to be sold.

How were the CVNA shares in this Form 144 acquired?

The 1,527 shares covered by the Form 144 were acquired on 12/12/2025 through the exercise of stock options, with the purchase price paid in cash on the same date.

What recent CVNA share sales by the insider are disclosed in the past 3 months?

The filing reports 10b5-1 sales for Paul Breaux: 8,473 shares on 12/11/2025 for $4,024,675.00, 20,000 shares on 12/08/2025 for $8,770,000.00, and 15,000 shares on 10/01/2025 for $5,970,000.00.

How many CVNA common shares are outstanding according to this Form 144?

The Form 144 states that there are 141,423,193 shares of the same class of CVNA common stock outstanding.

What representation does the insider make about CVNA's information in this Form 144?

By signing the notice, the insider represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.

Are the recent CVNA insider sales made under a Rule 10b5-1 trading plan?

Yes. The past 3 months of transactions are described as 10b5-1 Sales for Paul Breaux, indicating they were executed under a Rule 10b5-1 trading plan.